Valentina Magri | Ricerc@Sapienza

Pubblicazioni

Titolo	Pubblicato in	Anno
Early Detection of Disease Progression in Metastatic Cancers: Could CTCs Improve RECIST Criteria?	BIOMEDICINES	2024
Circulating Cancer-Associated Macrophage-like Cells as a Blood-Based Biomarker of Response to Immune Checkpoint Inhibitors	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES	2024
Blood Extracellular Vesicles beyond Circulating Tumour Cells: A Valuable Risk Stratification Biomarker in High-Risk Non-Muscle-Invasive Bladder Cancer Patients	BIOMEDICINES	2024
Exploring the utility of a NGS multigene panel to predict BCG response in patients with non-muscle invasive bladder cancer	ONCOLOGY RESEARCH	2024
Pregnancy-associated breast cancer: a diagnostic and therapeutic challenge	DIAGNOSTICS	2023
Genomic landscape and survival analysis of ctDNA “neo-RAS wild-type” patients with originally RAS mutant metastatic colorectal cancer	FRONTIERS IN ONCOLOGY	2023
Prognostic Role of Circulating Tumor Cell Trajectories in Metastatic Colorectal Cancer	CELLS	2023
Is cancer an intelligent species?	CANCER METASTASIS REVIEWS	2023
An organoid model of colorectal circulating tumor cells with stem cell features, hybrid EMT state and distinctive therapy response profile	JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH	2022
RAS mutation conversion in bevacizumab-treated metastatic colorectal cancer patients: a liquid biopsy based study	CANCERS	2022
Precision medicine in breast cancer: do MRI biomarkers identify patients who truly benefit from the Oncotype DX Recurrence Score® Test?	DIAGNOSTICS	2022
Eribulin in brain metastases of breast cancer. outcomes of the EBRAIM prospective observational trial	FUTURE ONCOLOGY	2021
Role of chemotherapy in vulvar cancers: time to rethink standard of care?	CANCERS	2021
Sequential isolation and characterization of single CTCs and large CTC clusters in metastatic colorectal cancer patients	CANCERS	2021
Impact of BMI on HER2+ metastatic breast cancer patients treated with pertuzumab and/or trastuzumab emtansine. Real-world evidence	JOURNAL OF CELLULAR PHYSIOLOGY	2020
Clinical Multigene Panel Sequencing Identifies Distinct Mutational Association Patterns in Metastatic Colorectal Cancer	FRONTIERS IN ONCOLOGY	2020
T-DM1 Efficacy in patients with HER2-positive metastatic breast cancer progressing after a Taxane Plus Pertuzumab and Trastuzumab. An italian multicenter observational study	CLINICAL BREAST CANCER	2020
Baseline CD44v6-positive circulating tumor cells to predict first-line treatment failure in patients with metastatic colorectal cancer	ONCOTARGET	2020
Palbociclib plus fulvestrant or everolimus plus exemestane for pretreated advanced breast cancer with lobular histotype in ER+/HERr2− patients: A propensity score-matched analysis of a multicenter retrospective patient series	JOURNAL OF PERSONALIZED MEDICINE	2020
Oncotype DX predictive nomogram for recurrence score output: the novel system ADAPTED01 based on quantitative immunochemistry analysis	CLINICAL BREAST CANCER	2020

Progetti di Ricerca

Value of PD-L1 positive CTCs as predictive marker of pCR during neoadjuvant chemotherapy in locally advanced breast cancer. Correlation with BRCA1/2 germline mutation.